Clinical trial

Validation of α-synuclein Modifications in Parkinson's dIsoRder Evolution

NCT06941012

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2025-05-12

PhaseN/A

Study timeline

Study start (actual)2025-05-12Date precision: day

Registry last updated2026-03-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson Disease (PD)unresolved

Interventions

Blood draw for the laboratory assessmentOTHER

Sponsors & collaborators

Casa di Cura IGEAlead sponsor

Asociación Parkinson Madridcollaborator

Aristotle University Of Thessalonikicollaborator

Institute of Psychiatry and Neurology, Warsawcollaborator

LINKCARE HEALTH SERVICES SLcollaborator

ALMAWAVE SPAcollaborator

European Brain Research Foundationcollaborator

Mapped research locations

MadridSpain1 WarsawPoland1 ThessalonikiGreece1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06941012 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.